Lv1
68 积分 2024-11-24 加入
Preclinical and first-in-human evaluation of VG-3927/SAR448851, an oral small-molecule TREM2 agonist for Alzheimer’s disease
12天前
已完结
Macropinocytosis-mediated recyclable LYTACs (McR-TACs) for receptor-independent protein degradation
1个月前
已完结
Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues
3个月前
已完结
Reshaping the progranulin/sortilin interaction for targeted degradation of extracellular proteins
6个月前
已完结
Safety considerations for cereblon-recruiting targeted protein degraders
6个月前
已关闭
Safety considerations for cereblon-recruiting targeted protein degraders
6个月前
已关闭
DEVELOPMENT OF E3 LIGANDS TO ENABLE NEXT-GENERATION DEGRADERS
9个月前
已完结
Molecular glues evolve from serendipity to rational design
10个月前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
10个月前
已完结
Efficient proximity labeling in living cells and organisms with TurboID
10个月前
已完结
皖公网安备34019202002308
